Voyager Therapeutics
VYGR
$7.46
Share price
2.90%
Change (1 day)
-50.83%
Change (1 year)
Voyager Therapeutics (VYGR) - Cash on Hand
Cash on Hand as of September 2024 : NZ$0.60 Billion
According to Voyager Therapeutics
's latest financial reports the company has NZ$0.60 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Voyager Therapeutics - Cash on Hand chart (from 2014 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | NZ$0.36 B | 95.03% |
| 2022-12-31 | NZ$0.18 B | -3.53% |
| 2021-12-31 | NZ$0.19 B | -22.71% |
| 2020-12-31 | NZ$0.25 B | -39.95% |
| 2019-12-31 | NZ$0.41 B | 79.97% |
| 2018-12-31 | NZ$0.23 B | -2.42% |
| 2017-12-31 | NZ$0.23 B | -5.47% |
| 2016-12-31 | NZ$0.25 B | -11.32% |
| 2015-12-31 | NZ$0.28 B | 3062.41% |
| 2014-12-31 | NZ$8.97 M | 5365.48% |
| 2013-12-31 | NZ$0.16 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 | NZ$0.44 B | -25.89% | 🇺🇸 USA |